Leukocyte Filter System - China

Blood Transfusion System

Filtration System

Product Description

Fosmedic developed the Leukocyte-reduction filter system that meet the regulatory guidelines and strict requirements of blood banks in Europe and the US markets.

Leukocyte-reduction filter system is designed for reducing the white blood cells in whole blood or red blood cell conentrates, preventing lots of ill-reaction in transfusion and reducing implant-anti-host and virus diseases from non-self's white blood cells.

This product is for removal of leukocyte in whole blood or MAP solution and for storage of MAP solution and clinical transfusion, no permission for any other usage.

· Leukocyte reduction ≥ 99.9%, residual white blood cells ≤ 2.5 X 106/unit

· Red cells recovery ≥ 85%

Anticoagulant: CPD+SAG- M Primary Bag Capacity: 350ml, 450ml, 500ml Satellite Bag Capacity: Available from 150ml to 450ml

Needle Gauge Size: 16G

Company Contact:

• Posted By: Shanghai Xingliao Trading Co.,Ltd.

• Phone: +86-21-52826603

• Address: Room 5C,5th Floor,No.427 Nujiang North Road,Putuo District,Shanghai,China., Shanghai , Shanghai , China

• Email:

• Website: https://www.fosmedic.com

• Business Description: Shanghai Xingliao Trading Co., Ltd.(Registered Main Brand : Fosmedic? ) also known as Fosmedic is a professional supplier for manufacturing and exporting disposable medical devices.
  
  The main products include surgical sutures, surgical blades, blood transfusion bags, transfusion sets, leukocyte filters and other medical supplies.
  
  It operates several reputable manufacturing plants located in Shanghai and Jiangsu respectively.
  
  All exported products have passed the CE and ISO certification.
  
  Recently the products have been distributed to over 40 countries and regions in Asia, Europe, Middle East, Africa, Oceania, North and South America.
  
  1st Class Quality, competitive pricing policy, perfect service system, and innovative technology has helped our products to be well recognized by global medical dealers, hospitals, blood banks, labs and clinics, as well as the health ministry of many countries and the Red Cross.
  
  Looking to the future, Fosmedic will continue to shoulder its social responsibilities, paying attention to the organization of personnel and team building, integrating medical industry resources, and finally improving its core competence to accomplish its strategic target of being a first-class enterprise in the global mainstream markets.